03 vs AIDS The Abbreviated History and Suppression of Ozone Therapy in the United States as of August 1993 or A Proven Documented and Successful Treatment for AIDS and Other Diseases Meets the International Wall
Tabled Paper 2148
Tabled Papers for 6th Assembly 1990 - 1994; Tabled Papers; ParliamentNT
Tabled by Denis Collins
Made available by the Legislative Assembly of the Northern Territory under Standing Order 240. Where copyright subsists with a third party it remains with the original owner and permission may be required to reuse the material.
1992 Dec 277+ H aitians imprisoned in HIV concentration camp. Guantanamo Naval Bases Camp Bulkeley in Cuba is their home at a cost of $55 million. 1992 Dec Aids Patient Care M agazine publishes in Vol. 6 No. 6 "Point Of View: A Case For Ozone Therapy" by Ed McCabe, a reprint of Mr. McCabes testimony before the NIH Office of Unconventional Medicine. "I have interviewed six U.S. M.D.s who, independent of each other, have collectively reported bringing over 300 AIDS patients to HIV negative status (confirmation with Western Blot, ELISA, and PCR), including complete eradication of any secondary disease factors such as energy loss, weight loss, diarrhea, etc." 1992 FDA announces the RU-486 abortion pill could be approved for sale in the U.S. based upon existing clinical trials in Europe which "may well be sufficient to permit an adequate review" of the drug by the federal agency, according to Carol R, Scheman deputy FDA commissioner for external affairs. Rep. Ron Wyden, D-Oregon, "With this letter, the FDA is clearing a path for quick approval, and is removing the regulatory roadblocks to permitting this drug into the United States." ' Comment: Funny that no one at the FDA can read German and study the over 6,000 clinical papers from 50 years of use on humans, giving millions of dosages of ozone to humans in Germany alone, to "remove the regulatory roadblocks." Equally interesting is that heart bypass operations were never approved by the FDA yet are commonplace. 1993 Ja n 3rd Seattle Times reported: The pharm aceutical industry earns $55 billion a year, and is the most profitable business in America. Drug companies increase prices without fear, protected from competition. The General Accounting Office ran into a wall o f silence when it undertook a study of drug price inflation. The, Office Of Technology Assessment said drug. v companies "have demonstrated a willingness to actively resist providing access to congressional- agencies..." The sales reps are everywhere. The typical U.S. doctor sees two or three a week. The influence begins the moment a medical or pharmacy student starts school and receives a : free stethoscope, free subscriptions, travel expenses to visit drug companies, or a graduation present, all compliments of a drug manufacturer. Kenneth Feather, head of surveillance and enforcement for the Food & Drug Administrationss drug marketing division, added: " I ts probably shocking to people who dont know, to find out the alm ost total control tha t the pharm aceutical industry has about the flow of medical inform ation." $13,000 per doctor per year is spent to influence the medical treatments you get. Senate hearings conclude: Medical education is determ ined by w hat the marketing departm ent wants, not w hat the doctors need. Drug companies spend $31 million a year to lobby lawmakers. 1993 Ja n 9th Ed M cCabe, during a lecture to the H um an Ecology Action League in room 218 of the Hunter School of Health Sciences in New York City, presents 4 patients to the media and those assembled. Three were AIDS patients and one a cancer patient all who had ozone 29
Aboriginal and Torres Strait Islander people are advised that this website may contain the names, voices and images of people who have died, as well as other culturally sensitive content. Please be aware that some collection items may use outdated phrases or words which reflect the attitude of the creator at the time, and are now considered offensive.
We use temporary cookies on this site to provide functionality.
You are welcome to provide further information or feedback about this item by emailing TerritoryStories@nt.gov.au